Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Weiser, TS; Guo, ZS; Ohnmacht, GA; Parkhurst, ML; Tong-On, P; Marincola, FM; Fischette, MR; Yu, XD; Chen, GA; Hong, JA; Stewart, JH; Nguyen, DM; Rosenberg, SA; Schrump, DS
   Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1
   JOURNAL OF IMMUNOTHERAPY
   
   T.S. Weiser et al., "Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1", J IMMUNOTH, 24(2), 2001, pp. 151-161
2. Zhang, JY; Chan, EKL; Peng, XX; Lu, ML; Wang, X; Mueller, F; Tan, EM
   Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies
   CLINICAL IMMUNOLOGY
   
   J.Y. Zhang et al., "Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies", CLIN IMMUNO, 100(2), 2001, pp. 149-156
3. Larsson, M; Fonteneau, JF; Bhardwaj, N
   Dendritic cells resurrect antigens from dead cells
   TRENDS IN IMMUNOLOGY
   
   M. Larsson et al., "Dendritic cells resurrect antigens from dead cells", TRENDS IMMU, 22(3), 2001, pp. 141-148
4. Bodey, B
   Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   B. Bodey, "Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells", EXPERT OP B, 1(4), 2001, pp. 603-617
5. Scanlan, MJ; Jager, D
   Challenges to the development of antigen-specific breast cancer vaccines
   BREAST CANCER RESEARCH
   
   M.J. Scanlan e D. Jager, "Challenges to the development of antigen-specific breast cancer vaccines", BREAST CA R, 3(2), 2001, pp. 95-98
6. Matzku, S; Zoller, M
   Specific immunotherapy of cancer in elderly patients
   DRUGS & AGING
   
   S. Matzku e M. Zoller, "Specific immunotherapy of cancer in elderly patients", DRUG AGING, 18(9), 2001, pp. 639-664
7. Kossoy, G; Ben-Hur, H; Kossoy, N; Zusman, I
   Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   G. Kossoy et al., "Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors", INT J MOL M, 7(2), 2001, pp. 221-224
8. Romero, P; Dutoit, V; Rubio-Godoy, V; Lienard, D; Speiser, D; Guillaume, P; Servis, K; Rimoldi, D; Cerottini, JC; Valmori, D
   CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences
   CLINICAL CANCER RESEARCH
   
   P. Romero et al., "CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences", CLIN CANC R, 7(3), 2001, pp. 766S-772S
9. Schreiber, K; Wu, TH; Kast, WM; Schreiber, H
   Tracking the common ancestry of antigenically distinct cancer variants
   CLINICAL CANCER RESEARCH
   
   K. Schreiber et al., "Tracking the common ancestry of antigenically distinct cancer variants", CLIN CANC R, 7(3), 2001, pp. 871S-875S
10. Nishiyama, T; Tachibana, M; Horiguchi, Y; Nakamura, K; Ikeda, Y; Takesako, K; Murai, M
    Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
    CLINICAL CANCER RESEARCH
    
    T. Nishiyama et al., "Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide", CLIN CANC R, 7(1), 2001, pp. 23-31
11. Hansen, MH; Ostenstad, B; Sioud, M
    Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
    MOLECULAR MEDICINE
    
    M.H. Hansen et al., "Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients", MOL MED, 7(4), 2001, pp. 230-239
12. Dunussi-Joannopoulos, K; Leonard, JP
    Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia
    LEUKEMIA & LYMPHOMA
    
    K. Dunussi-Joannopoulos e J.P. Leonard, "Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia", LEUK LYMPH, 41(5-6), 2001, pp. 483
13. Maki, RG
    Soft tissue sarcoma as a model disease to examine cancer immunotherapy
    CURRENT OPINION IN ONCOLOGY
    
    R.G. Maki, "Soft tissue sarcoma as a model disease to examine cancer immunotherapy", CURR OPIN O, 13(4), 2001, pp. 270-274
14. Gunzer, M; Grabbe, S
    Dendritic cells in cancer immunotherapy
    CRITICAL REVIEWS IN IMMUNOLOGY
    
    M. Gunzer e S. Grabbe, "Dendritic cells in cancer immunotherapy", CR R IMMUN, 21(1-3), 2001, pp. 133-145
15. Disis, ML; Knutson, KL; McNeel, DG; Davis, D; Schiffman, K
    Clinical translation of peptide-based vaccine trials: The HER-2/neu model
    CRITICAL REVIEWS IN IMMUNOLOGY
    
    M.L. Disis et al., "Clinical translation of peptide-based vaccine trials: The HER-2/neu model", CR R IMMUN, 21(1-3), 2001, pp. 263-273
16. Ben-Hur, H; Kossoy, G; Zusman, I
    Soluble low-molecular-mass tumor-associated proteins promote the suppression of mammary tumors by cyclophosphamide
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    H. Ben-Hur et al., "Soluble low-molecular-mass tumor-associated proteins promote the suppression of mammary tumors by cyclophosphamide", INT J ONCOL, 19(2), 2001, pp. 407-411
17. Zheng, CX; Zhan, WH; Zhao, JZ; Zheng, D; Wang, DP; He, YL; Zheng, ZQ
    The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    C.X. Zheng et al., "The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer", WORLD J GAS, 7(3), 2001, pp. 431-434
18. Hsu, KF; Hung, CF; Cheng, WF; He, L; Slater, LA; Ling, M; Wu, TC
    Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
    GENE THERAPY
    
    K.F. Hsu et al., "Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen", GENE THER, 8(5), 2001, pp. 376-383
19. Roopchand, DE; Lee, JM; Shahinian, S; Paquette, D; Bussey, H; Branton, PE
    Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A
    ONCOGENE
    
    D.E. Roopchand et al., "Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A", ONCOGENE, 20(38), 2001, pp. 5279-5290
20. Struss, AK; Romeike, BFM; Munnia, A; Nastainczyk, W; Steudel, WI; Konig, J; Ohgaki, H; Feiden, W; Fischer, U; Meese, E
    PHF3-specific antibody responses in over 60% of patients with glioblastomamultiforme
    ONCOGENE
    
    A.K. Struss et al., "PHF3-specific antibody responses in over 60% of patients with glioblastomamultiforme", ONCOGENE, 20(31), 2001, pp. 4107-4114
21. Ruediger, R; Pham, HT; Walter, G
    Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene
    ONCOGENE
    
    R. Ruediger et al., "Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene", ONCOGENE, 20(15), 2001, pp. 1892-1899
22. Ruediger, R; Pham, HT; Walter, G
    Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene
    ONCOGENE
    
    R. Ruediger et al., "Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene", ONCOGENE, 20(1), 2001, pp. 10-15
23. Zhu, T; Boons, GJ
    A highly efficient synthetic strategy for polymeric support synthesis of Le(x), Le(y), and H-type 2 oligosaccharides
    CHEMISTRY-A EUROPEAN JOURNAL
    
    T. Zhu e G.J. Boons, "A highly efficient synthetic strategy for polymeric support synthesis of Le(x), Le(y), and H-type 2 oligosaccharides", CHEM-EUR J, 7(11), 2001, pp. 2382-2389
24. Renner, C; Kubuschok, B; Trumper, L; Pfreundschuh, M
    Clinical approaches to vaccination in oncology
    ANNALS OF HEMATOLOGY
    
    C. Renner et al., "Clinical approaches to vaccination in oncology", ANN HEMATOL, 80(5), 2001, pp. 255-266
25. Tanaka, K; Kondoh, N; Shuda, M; Matsubara, O; Imazeki, N; Ryo, A; Wakatsuki, T; Hada, A; Goseki, N; Igari, T; Hatsuse, K; Aihara, T; Horiuchi, S; Yamamoto, N; Yamamoto, M
    Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    
    K. Tanaka et al., "Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas", BBA-MOL BAS, 1536(1), 2001, pp. 1-12
26. Scherneck, S; Ulrich, R; Feunteun, J
    The hamster polyomavirus - a brief review of recent knowledge
    VIRUS GENES
    
    S. Scherneck et al., "The hamster polyomavirus - a brief review of recent knowledge", VIRUS GENES, 22(1), 2001, pp. 93-101
27. Comtesse, N; Reus, K; Meese, E
    The MGEA6 multigene family has an active locus on 14q and at least nine pseudogenes on different chromosomes
    GENOMICS
    
    N. Comtesse et al., "The MGEA6 multigene family has an active locus on 14q and at least nine pseudogenes on different chromosomes", GENOMICS, 75(1-3), 2001, pp. 43-48
28. Van Tendeloo, VFI; Van Broeckhoven, C; Berneman, ZN
    Gene-based cancer vaccines: an ex vivo approach
    LEUKEMIA
    
    V.F.I. Van Tendeloo et al., "Gene-based cancer vaccines: an ex vivo approach", LEUKEMIA, 15(4), 2001, pp. 545-558
29. Chambost, H; van Baren, N; Brasseur, F; Olive, D
    MAGE-A genes are not expressed in human leukemias
    LEUKEMIA
    
    H. Chambost et al., "MAGE-A genes are not expressed in human leukemias", LEUKEMIA, 15(11), 2001, pp. 1769-1771
30. Sugano, M; Conway, TF; Kelleher, RJ; Sugiyama, Y; Chen, FA; Bankert, RB; Bernstein, SH
    Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-Class II restricted T-cell response
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    
    M. Sugano et al., "Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-Class II restricted T-cell response", J EXP CL C, 20(2), 2001, pp. 175-182
31. Kusumoto, M; Umeda, S; Ikubo, A; Aoki, Y; Tawfik, O; Oben, R; Williamson, S; Jewell, W; Suzuki, T
    Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    M. Kusumoto et al., "Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene", CANCER IMMU, 50(7), 2001, pp. 373-381
32. Janerich, DT
    The fetal antigen hypothesis: cancers and beyond
    MEDICAL HYPOTHESES
    
    D.T. Janerich, "The fetal antigen hypothesis: cancers and beyond", MED HYPOTH, 56(1), 2001, pp. 101-103
33. Chen, CH; Chen, CJ; Lee, HS; Huang, GT; Yang, PM; Tsai, LJ; Chen, DS; Sheu, JC
    Expressions of cancer-testis antigens in human hepatocellular carcinomas
    CANCER LETTERS
    
    C.H. Chen et al., "Expressions of cancer-testis antigens in human hepatocellular carcinomas", CANCER LETT, 164(2), 2001, pp. 189-195
34. Nijman, HW; van Diest, PJ; Poort-Keesom, RJJ; von Mensdorff-Pouilly, S; Verstraeten, RA; Kummer, A; Meijer, CJLM; Melief, CJM; Hilgers, J; Kenemans, P
    T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    H.W. Nijman et al., "T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer", EUR J OB GY, 94(1), 2001, pp. 114-120
35. Pistolesi, S; Nuti, M; Castagna, M; Pingitore, R
    Mammary fetal gland: Identification of new oncofetal antigens by monoclonal antibodies B72.3, MM1.80 and 4.36
    TUMORI
    
    S. Pistolesi et al., "Mammary fetal gland: Identification of new oncofetal antigens by monoclonal antibodies B72.3, MM1.80 and 4.36", TUMORI, 87(4), 2001, pp. 252-255
36. McNeel, DG; Nguyen, LD; Ellis, WJ; Higano, CS; Lange, PH; Disis, ML
    Naturally occurring prostate cancer antigen-specific T cell responses of aTh1 phenotype can be detected in patients with prostate cancer
    PROSTATE
    
    D.G. McNeel et al., "Naturally occurring prostate cancer antigen-specific T cell responses of aTh1 phenotype can be detected in patients with prostate cancer", PROSTATE, 47(3), 2001, pp. 222-229
37. Goel, A; Batra, SK
    Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    
    A. Goel e S.K. Batra, "Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer", TER CAR MUT, 21(1), 2001, pp. 45-57
38. Niethammer, AG; Primus, FJ; Xiang, R; Dolman, CS; Ruehlmann, JM; Ba, Y; Gillies, SD; Reisfeld, RA
    An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
    VACCINE
    
    A.G. Niethammer et al., "An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice", VACCINE, 20(3-4), 2001, pp. 421-429
39. Chang, JS; Choi, MJ; Cheong, HS; Kim, K
    Development of Th1-mediated CD8+effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes
    VACCINE
    
    J.S. Chang et al., "Development of Th1-mediated CD8+effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes", VACCINE, 19(27), 2001, pp. 3608-3614
40. Moingeon, P
    Cancer vaccines
    VACCINE
    
    P. Moingeon, "Cancer vaccines", VACCINE, 19(11-12), 2001, pp. 1305-1326
41. Berthet, FX; Coche, T; Vinals, C
    Applied genome research in the field of human vaccines
    JOURNAL OF BIOTECHNOLOGY
    
    F.X. Berthet et al., "Applied genome research in the field of human vaccines", J BIOTECH, 85(2), 2001, pp. 213-226
42. Adamson, PJ; Zola, H; Nicholson, IC; Pilkington, G; Hohmann, A
    Antibody against CD20 in patients with B cell malignancy
    LEUKEMIA RESEARCH
    
    P.J. Adamson et al., "Antibody against CD20 in patients with B cell malignancy", LEUK RES, 25(12), 2001, pp. 1047-1050
43. Lieberman, SM; Horig, H; Kaufman, HL
    Innovative treatments for pancreatic cancer
    SURGICAL CLINICS OF NORTH AMERICA
    
    S.M. Lieberman et al., "Innovative treatments for pancreatic cancer", SURG CL NA, 81(3), 2001, pp. 715
44. Jager, D; Jagar, E; Knuth, A
    Vaccination for malignant melanoma: Recent developments
    ONCOLOGY
    
    D. Jager et al., "Vaccination for malignant melanoma: Recent developments", ONCOL-BASEL, 60(1), 2001, pp. 1-7
45. Eichmuller, S; Usener, D; Dummer, R; Stein, A; Thiel, D; Schadendorf, D
    Serological detection of cutaneous T-cell lymphoma-associated antigens
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    S. Eichmuller et al., "Serological detection of cutaneous T-cell lymphoma-associated antigens", P NAS US, 98(2), 2001, pp. 629-634
46. Brichory, FM; Misek, DE; Yim, AM; Krause, MC; Giordano, TJ; Beer, DG; Hanash, SM
    An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    F.M. Brichory et al., "An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer", P NAS US, 98(17), 2001, pp. 9824-9829
47. Gaillard, S; Fahrbach, KM; Parkati, R; Rundell, K
    Overexpression of simian virus 40 small-t antigen blocks centrosome function and mitotic progression in human fibroblasts
    JOURNAL OF VIROLOGY
    
    S. Gaillard et al., "Overexpression of simian virus 40 small-t antigen blocks centrosome function and mitotic progression in human fibroblasts", J VIROLOGY, 75(20), 2001, pp. 9799-9807
48. Galetto, A; Contarini, M; Sapino, A; Cassoni, P; Consalvo, E; Forno, S; Pezzi, C; Barnaba, V; Mussa, A; Matera, L
    Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells
    JOURNAL OF SURGICAL RESEARCH
    
    A. Galetto et al., "Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells", J SURG RES, 100(1), 2001, pp. 32-38
49. Palermo, B; Campanelli, R; Garbelli, S; Mantovani, S; Lantelme, E; Brazzelli, V; Ardigo, M; Borroni, G; Martinetti, M; Badulli, C; Necker, A; Giachino, C
    Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY
    
    B. Palermo et al., "Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo", J INVES DER, 117(2), 2001, pp. 326-332
50. Salio, M; Shepherd, D; Dunbar, PR; Palmowski, M; Murphy, K; Wu, LJ; Cerundolo, V
    Mature dendritic cells prime functionally superior melan-A-specific CD8(+)lymphocytes as compared with nonprofessional APC
    JOURNAL OF IMMUNOLOGY
    
    M. Salio et al., "Mature dendritic cells prime functionally superior melan-A-specific CD8(+)lymphocytes as compared with nonprofessional APC", J IMMUNOL, 167(3), 2001, pp. 1188-1197
51. Gulyas, M; Kaposi, AD; Elek, G; Szollar, LG; Hjerpe, A
    Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology
    JOURNAL OF CLINICAL PATHOLOGY
    
    M. Gulyas et al., "Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology", J CLIN PATH, 54(11), 2001, pp. 831-835
52. Tan, EM
    Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis
    JOURNAL OF CLINICAL INVESTIGATION
    
    E.M. Tan, "Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis", J CLIN INV, 108(10), 2001, pp. 1411-1415
53. Colella, S; Ohgaki, H; Ruediger, R; Yang, F; Nakamura, M; Fujisawa, H; Kleihues, P; Walter, G
    Reduced expression of the A alpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the A alpha and A beta subunit genes
    INTERNATIONAL JOURNAL OF CANCER
    
    S. Colella et al., "Reduced expression of the A alpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the A alpha and A beta subunit genes", INT J CANC, 93(6), 2001, pp. 798-804
54. Lally, KM; Mocellin, S; Ohnmacht, GA; Nielsen, MB; Bettinotti, M; Panelli, MC; Monsurro, V; Marincola, FM
    Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading
    INTERNATIONAL JOURNAL OF CANCER
    
    K.M. Lally et al., "Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading", INT J CANC, 93(6), 2001, pp. 841-847
55. Harada, K; Yamada, A; Yang, DM; Itoh, K; Shichijo, S
    Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation
    INTERNATIONAL JOURNAL OF CANCER
    
    K. Harada et al., "Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation", INT J CANC, 93(5), 2001, pp. 623-628
56. Linnebacher, M; Gebert, J; Rudy, W; Woerner, S; Yuan, YP; Bork, P; Doeberitz, MV
    Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens
    INTERNATIONAL JOURNAL OF CANCER
    
    M. Linnebacher et al., "Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens", INT J CANC, 93(1), 2001, pp. 6-11
57. Jungbluth, AA; Chen, YT; Stockert, E; Busam, KJ; Kolb, D; Iversen, K; Coplan, K; Williamson, B; Altorki, N; Old, LJ
    Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
    INTERNATIONAL JOURNAL OF CANCER
    
    A.A. Jungbluth et al., "Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues", INT J CANC, 92(6), 2001, pp. 856-860
58. Geissler, M; Mohr, L; Weth, R; Kohler, G; Grimm, CF; Krohne, TU; Von Weizsacker, F; Blum, HE
    Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice
    GASTROENTEROLOGY
    
    M. Geissler et al., "Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice", GASTROENTY, 121(4), 2001, pp. 931-939
59. Schneider, MB; Matsuzaki, H; Haorah, J; Ulrich, A; Standop, J; Ding, XZ; Adrian, TE; Pour, PM
    Prevention of pancreatic cancer induction in hamsters by metformin
    GASTROENTEROLOGY
    
    M.B. Schneider et al., "Prevention of pancreatic cancer induction in hamsters by metformin", GASTROENTY, 120(5), 2001, pp. 1263-1270
60. Benlalam, H; Labarriere, N; Linard, B; Derre, L; Diez, E; Pandolfino, MC; Bonneville, M; Jotereau, F
    Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    H. Benlalam et al., "Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy", EUR J IMMUN, 31(7), 2001, pp. 2007-2015
61. Sioud, M; Hansen, MH
    Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    M. Sioud e M.H. Hansen, "Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries", EUR J IMMUN, 31(3), 2001, pp. 716-725
62. Stauss, HJ
    Benign autoimmunity to combat malignancy
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    H.J. Stauss, "Benign autoimmunity to combat malignancy", CLIN EXP IM, 125(1), 2001, pp. 1-2
63. Zhang, JY; Zhu, W; Imai, H; Kiyosawa, K; Chan, EKL; Tan, EM
    De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    J.Y. Zhang et al., "De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma", CLIN EXP IM, 125(1), 2001, pp. 3-9
64. You, ZY; Huang, X; Hester, J; Toh, HC; Chen, SY
    Targeting dendritic cells to enhance DNA vaccine potency
    CANCER RESEARCH
    
    Z.Y. You et al., "Targeting dendritic cells to enhance DNA vaccine potency", CANCER RES, 61(9), 2001, pp. 3704-3711
65. Jager, D; Stockert, E; Gure, AO; Scanlan, MJ; Karbach, J; Jager, E; Knuth, A; Old, LJ; Chen, YT
    Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library
    CANCER RESEARCH
    
    D. Jager et al., "Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library", CANCER RES, 61(5), 2001, pp. 2055-2061
66. McNeel, DG; Nguyen, LD; Disis, ML
    Identification of T helper epitopes from prostatic acid phosphatase
    CANCER RESEARCH
    
    D.G. McNeel et al., "Identification of T helper epitopes from prostatic acid phosphatase", CANCER RES, 61(13), 2001, pp. 5161-5167
67. Pascolo, S; Schirle, M; Guckel, B; Dumrese, T; Stumm, S; Kayser, S; Moris, A; Wallwiener, D; Rammensee, HG; Stevanovic, S
    A MAGE-A1 HLA-A*0201 epitope identified by mass spectrometry
    CANCER RESEARCH
    
    S. Pascolo et al., "A MAGE-A1 HLA-A*0201 epitope identified by mass spectrometry", CANCER RES, 61(10), 2001, pp. 4072-4077
68. Zambon, A; Mandruzzato, S; Parenti, A; Macino, B; Dalerba, P; Ruol, A; Merigliano, S; Zaninotto, G; Zanovello, P
    MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia
    CANCER
    
    A. Zambon et al., "MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia", CANCER, 91(10), 2001, pp. 1882-1888
69. Chouaib, S; Echchakir, H; Angevin, E; Guerra, N; Kosmatopoulos, K; Caignard, A; Lim, A; Baron, V; Ferradini, L; Mami-Chouaib, F
    Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring
    BULLETIN DU CANCER
    
    S. Chouaib et al., "Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring", B CANCER, 88(8), 2001, pp. 733-740
70. Reid, CDL
    Dendritic cells and immunotherapy for malignant disease
    BRITISH JOURNAL OF HAEMATOLOGY
    
    C.D.L. Reid, "Dendritic cells and immunotherapy for malignant disease", BR J HAEM, 112(4), 2001, pp. 874-887
71. Weiser, TS; Ohnmacht, GA; Guo, ZS; Fischette, MR; Chen, GA; Hong, JA; Nguyen, DM; Schrump, DS
    Induction of MAGE-3 expression in lung and esophageal cancer cells
    ANNALS OF THORACIC SURGERY
    
    T.S. Weiser et al., "Induction of MAGE-3 expression in lung and esophageal cancer cells", ANN THORAC, 71(1), 2001, pp. 295-301
72. Engelhard, VH; Bullock, TNV; Colella, TA; Mullins, DW
    Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use
    CANCER JOURNAL
    
    V.H. Engelhard et al., "Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use", CANCER J, 6, 2000, pp. S272-S280
73. Ladanyi, A; Nishimura, MI; Rosenberg, SA; Yang, JC
    Tumorigenicity and immunogenicity of murine tumor cells expressing an MHC class II molecule with a covalently bound antigenic peptide
    JOURNAL OF IMMUNOTHERAPY
    
    A. Ladanyi et al., "Tumorigenicity and immunogenicity of murine tumor cells expressing an MHC class II molecule with a covalently bound antigenic peptide", J IMMUNOTH, 23(1), 2000, pp. 36-47
74. Pietersz, GA; Apostolopoulos, V; McKenzie, IFC
    Generation of cellular immune responses to antigenic tumor peptides
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    G.A. Pietersz et al., "Generation of cellular immune responses to antigenic tumor peptides", CELL MOL L, 57(2), 2000, pp. 290-310
75. Bodey, B; Bodey, B; Siegel, SE; Kaiser, HE
    Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents
    CURRENT PHARMACEUTICAL DESIGN
    
    B. Bodey et al., "Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents", CUR PHARM D, 6(3), 2000, pp. 261-276
76. Jiang, XP; Yang, DC; Elliott, RL; Head, JF
    Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125 - Results in immune and clinical responses in breast cancer patients
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    X.P. Jiang et al., "Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125 - Results in immune and clinical responses in breast cancer patients", CANC BIO R, 15(5), 2000, pp. 495-505
77. Molldrem, JJ; Lee, PP; Wang, CQ; Felio, K; Kantarjian, HM; Champlin, RE; Davis, MM
    Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia
    NATURE MEDICINE
    
    J.J. Molldrem et al., "Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia", NAT MED, 6(9), 2000, pp. 1018-1023
78. Ishigami, S; Natsugoe, S; Hokita, S; Che, XM; Aridome, K; Iwashige, H; Tokuda, K; Nakajo, A; Miyazono, F; Aikou, T
    Intranodal antitumor immunocyte infiltration in node-negative gastric cancers
    CLINICAL CANCER RESEARCH
    
    S. Ishigami et al., "Intranodal antitumor immunocyte infiltration in node-negative gastric cancers", CLIN CANC R, 6(7), 2000, pp. 2611-2617
79. Gilewski, T; Adluri, S; Ragupathi, G; Zhang, SL; Yao, TJ; Panageas, K; Moynahan, M; Houghton, A; Norton, L; Livingston, PO
    Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21
    CLINICAL CANCER RESEARCH
    
    T. Gilewski et al., "Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21", CLIN CANC R, 6(5), 2000, pp. 1693-1701
80. Eura, M; Chikamatsu, K; Katsura, F; Obata, A; Sobao, Y; Takiguchi, M; Song, YS; Appella, E; Whiteside, TL; DeLeo, AB
    A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck
    CLINICAL CANCER RESEARCH
    
    M. Eura et al., "A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck", CLIN CANC R, 6(3), 2000, pp. 979-986
81. Anderson, BW; Peoples, GE; Murray, JL; Gillogly, MA; Gershenson, DM; Ioannides, CG
    Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals
    CLINICAL CANCER RESEARCH
    
    B.W. Anderson et al., "Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals", CLIN CANC R, 6(11), 2000, pp. 4192-4200
82. Whiteside, TL
    Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    T.L. Whiteside, "Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy", CL DIAG LAB, 7(3), 2000, pp. 327-332
83. Antonia, SJ; Sotomayor, E
    Gene therapy for lung cancer
    CURRENT OPINION IN ONCOLOGY
    
    S.J. Antonia e E. Sotomayor, "Gene therapy for lung cancer", CURR OPIN O, 12(2), 2000, pp. 138-142
84. Plate, JMD; Harris, JE
    Immune cell functions in pancreatic cancer
    CRITICAL REVIEWS IN IMMUNOLOGY
    
    J.M.D. Plate e J.E. Harris, "Immune cell functions in pancreatic cancer", CR R IMMUN, 20(5), 2000, pp. 375-392
85. Hamada, H; Kohno, N; Yokoyama, A; Kondo, K; Yang, SZ; Hiwada, K; Watanabe, K; Miyake, M
    A novel monoclonal antibody, H9, directed against the core protein of MUC1mucin
    ONCOLOGY REPORTS
    
    H. Hamada et al., "A novel monoclonal antibody, H9, directed against the core protein of MUC1mucin", ONCOL REP, 7(2), 2000, pp. 225-232
86. Nicolini, A; Carpi, A
    Postoperative follow-up of breast cancer patients: Overview and progress in the use of tumor markers
    TUMOR BIOLOGY
    
    A. Nicolini e A. Carpi, "Postoperative follow-up of breast cancer patients: Overview and progress in the use of tumor markers", TUMOR BIOL, 21(4), 2000, pp. 235-248
87. Marton, I; Johnson, SE; Damjanov, I; Currier, KS; Sundberg, JP; Knowles, BB
    Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas
    TRANSGENIC RESEARCH
    
    I. Marton et al., "Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas", TRANSGEN RE, 9(2), 2000, pp. 115-125
88. Gibbs, P; Hutchins, AM; Dorian, KT; Vaughan, HA; Davis, ID; Silvapulle, M; Cebon, JS
    MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma
    MELANOMA RESEARCH
    
    P. Gibbs et al., "MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma", MELANOMA RE, 10(3), 2000, pp. 259-264
89. Virshup, DM
    Protein phosphatase 2A: a panoply of enzymes
    CURRENT OPINION IN CELL BIOLOGY
    
    D.M. Virshup, "Protein phosphatase 2A: a panoply of enzymes", CURR OP CEL, 12(2), 2000, pp. 180-185
90. Lagarkova, MA; Boitchenko, VE; Mescheryakov, AA; Kashkarova, UA; Nedospasov, SA
    Human cortactin as putative cancer antigen
    ONCOGENE
    
    M.A. Lagarkova et al., "Human cortactin as putative cancer antigen", ONCOGENE, 19(45), 2000, pp. 5204-5207
91. Salehi, AH; Roux, PP; Kubu, CJ; Zeindler, C; Bhakar, A; Tannis, LL; Verdi, JM; Barker, PA
    NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis
    NEURON
    
    A.H. Salehi et al., "NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis", NEURON, 27(2), 2000, pp. 279-288
92. Kawakami, Y; Suzuki, Y; Shofuda, T; Kiniwa, Y; Inozume, T; Dan, K; Sakurai, T; Fujita, T
    T cell immune responses against melanoma and melanocytes in cancer and autoimmunity
    PIGMENT CELL RESEARCH
    
    Y. Kawakami et al., "T cell immune responses against melanoma and melanocytes in cancer and autoimmunity", PIGM CELL R, 13, 2000, pp. 163-169
93. Bendandi, M
    Anti-idiotype vaccines for human follicular lymphoma
    LEUKEMIA
    
    M. Bendandi, "Anti-idiotype vaccines for human follicular lymphoma", LEUKEMIA, 14(8), 2000, pp. 1333-1339
94. Berke, Z; Andersen, MH; Pedersen, M; Fugger, L; Zeuthen, J; Haurum, JS
    Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules
    LEUKEMIA
    
    Z. Berke et al., "Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules", LEUKEMIA, 14(3), 2000, pp. 419-426
95. Barrera, JL; Verastegui, E; Meneses, A; Zinser, J; de la Garza, J; Hadden, JW
    Combination immunotherapy of squamous cell carcinoma of the head and neck - A phase 2 trial
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    
    J.L. Barrera et al., "Combination immunotherapy of squamous cell carcinoma of the head and neck - A phase 2 trial", ARCH OTOLAR, 126(3), 2000, pp. 345-351
96. Sogn, JA
    The status of tumor immunology and cancer immunotherapy - Introduction
    IMMUNOLOGICAL INVESTIGATIONS
    
    J.A. Sogn, "The status of tumor immunology and cancer immunotherapy - Introduction", IMMUNOL INV, 29(2), 2000, pp. 81-84
97. Fong, L; Engleman, EG
    Dendritic cells in cancer immunotherapy
    ANNUAL REVIEW OF IMMUNOLOGY
    
    L. Fong e E.G. Engleman, "Dendritic cells in cancer immunotherapy", ANN R IMMUN, 18, 2000, pp. 245-273
98. Dannull, J; Cerny, T; Ackermann, DK; Groettrup, M
    Current status of dendritic cell-based-tumor vaccination
    ONKOLOGIE
    
    J. Dannull et al., "Current status of dendritic cell-based-tumor vaccination", ONKOLOGIE, 23(6), 2000, pp. 544-551
99. Brewis, N; Ohst, K; Fields, K; Rapacciuolo, A; Chou, D; Bloor, C; Dillmann, W; Rockman, H; Walter, G
    Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit ofprotein phosphatase 2A
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    
    N. Brewis et al., "Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit ofprotein phosphatase 2A", AM J P-HEAR, 279(3), 2000, pp. H1307-H1318
100. Pfreundschuh, M
     Exploitation of the B cell repertoire for the identification of human tumor antigens
     CANCER CHEMOTHERAPY AND PHARMACOLOGY
     
     M. Pfreundschuh, "Exploitation of the B cell repertoire for the identification of human tumor antigens", CANC CHEMOT, 46, 2000, pp. S3-S7